MT1-MMP-Mediated cleavage of decorin in corneal angiogenesis

Journal of Vascular Research

Volumn 46, Issue 6, 2009, Pages 541-550

  Mimura, Tatsuya ^a   Han, Kyu Yeon ^a   Onguchi, Tatsuya ^a   Chang, Jin Hong ^a,b   Kim, Tae Im ^b   Kojima, Takashi ^a,b   Zhou, Zhongjun ^c   Azar, Dimitri T ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiogenesis; Corneal neovascularization; Decorin; Extracellular matrix; Membrane type 1 matrix metalloproteinase; Metalloproteinase; MMP 14

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; DECORIN; MATRIX METALLOPROTEINASE 14;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CELL LYSATE; CONTROLLED STUDY; CORNEA; CORNEA CELL; FIBROBLAST CULTURE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR RING; WESTERN BLOTTING;

ANIMALS; AORTA; CELL LINE; CORNEA; CORNEAL NEOVASCULARIZATION; CULTURE MEDIA, CONDITIONED; DIPEPTIDES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; FIBROBLAST GROWTH FACTOR 2; KINETICS; MATRIX METALLOPROTEINASE 14; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEASE INHIBITORS; PROTEOGLYCANS; RECOMBINANT PROTEINS; TISSUE CULTURE TECHNIQUES; TRANSFECTION;

EID: 67649424445     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000226222     Document Type: Article

References (41)

1. Folkman J: Angiogenesis. Annu Rev Med 2006; 57:1-18
2. Azar DT: Corneal angiogenic privilege: an-giogenic and antiangiogenic factors in cor-neal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2006; 104:264-302
3. Chang JH, Gabison EE, Kato T, Azar DT: Corneal neovascularization. Curr Opin Ophthalmol 2001; 12:242-249
4. Raffetto JD, Khalil RA: Matrix metallopro-teinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008; 75:346-359
5. Rundhaug JE: Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005; 9: 267-285
6. Werb Z, Chin JR: Extracellular matrix remodeling during morphogenesis. Ann NY Acad Sci 1998; 857:110-118
7. Nagase H: Activation mechanisms of matrix metalloproteinases. Biol Chem 1997; 378: 151-160
8. Nagase H, Visse R, Murphy G: Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 20 06; 69: 562-573
9. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M: Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 1996; 393:101-104
10. Sato H, Seiki M: Membrane-type matrix me-talloproteinases (MT-MMPS) in tumor metastasis. J Biochem (Tokyo) 1996; 119: 209-215
11. d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G: Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 1997; 250:751-757
12. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y: Membrane type 1 matrix metallo-proteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997; 272:2446-2451
13. Koshikawa N, Schenk S, Moeckel G, Sharabi A, Miyazaki K, Gardner H, Zent R, Quar-anta V: Proteolytic processing of laminin-5 by MT1-MMP in tissues and its effects on epithelial cell morphology. FASEB J 2004; 18: 364-366
14. Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ: Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998; 95: 365-377
15. Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, Friedl P: Multi-step pericel-lular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 2007; 9:893-904
16. Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P: MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 2007; 109:4055-4063
17. Filippov S, Koenig GC, Chun TH, Hotary KB, Ota I, Bugge TH, Roberts JD, Fay WP, Birkedal-Hansen H, Holmbeck K, Sabeh F, Allen ED, Weiss SJ: MT1-matrix metallopro-teinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. J Exp Med 2005; 202:663-671
18. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ: Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional ext racellu lar matrix. Cell 20 03; 114 : 33-45
19. Nagase H: Cell surface activation of progela-tinase A (proMMP-2) and cell migration. Cell Res 1998; 8:179-186
20. Seiki M, Mori H, Kajita M, Uekita T, Itoh Y: Membrane-type 1 matrix metalloproteinase and cell migration. Biochem Soc Symp 2003; 70: 253-262
21. Li Y, Aoki T, Mori Y, Ahmad M, Miyamori H, Takino T, Sato H: Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar. Cancer Res 20 04; 64: 7058-706 4
22. Abd El-Aziz SH, Endo Y, Miyamaori H, Takino T, Sato H: Cleavage of growth differentiation factor 15 (GDF15) by membrane type 1-matrix metalloproteinase abrogates GDF15-mediated suppression of tumor cell growth. Cancer Sci 2007; 98:1330-1335
23. Hotary KB, Yana I, Sabeh F, Li XY, Holm-beck K, Birkedal-Hansen H, Allen ED, Hi-raoka N, Weiss SJ: Matrix metalloproteinas-es (MMPS) regulate fibrin-invasive activity via MT1-MMP-dependent and-independent processes. J Exp Med 2002; 195:295-308
24. Cao J, Chiarelli C, Kozarekar P, Adler HL: Membrane type 1-matrix metalloproteinase promotes human prostate cancer invasion and metastasis. Thromb Haemost 2005; 93: 770-778
25. Oblander SA, Zhou Z, Galvez BG, Starcher B, Shannon JM, Durbeej M, Arroyo AG, Tryggvason K, Apte SS: Distinctive functions of membrane type 1 matrix-metallo-protease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation. Dev Biol 2005; 277:255-269
26. McEwan PA, Scott PG, Bishop PN, Bella J: Structural correlations in the family of small leucine-rich repeat proteins and proteogly-cans. J Struct Biol 2006; 155: 294-305
27. Hocking AM, Shinomura T, McQuillan DJ: Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 1998; 17: 1-19
28. Davies Cde L, Melder RJ, Munn LL, Mouta-Carreira C, Jain RK, Boucher Y: Decorin inhibits endothelial migration and tube-like structure formation: role of thrombospon-din-1. Microvasc Res 2001; 62:26-42
29. Sulochana KN, Fan H, Jois S, Subramanian V, Sun F, Kini RM, Ge R: Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis. J Biol Chem 2005; 280: 27935-27948
30. Schonherr E, Sunderkotter C, Iozzo RV, Schaefer L: Decorin, a novel player in the insulin-like growth factor system. J Biol Chem 2005; 280: 15767-15772
31. Schonherr E, Sunderkotter C, Schaefer L, Thanos S, Grassel S, Oldberg A, Iozzo RV, Young MF, Kresse H: Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J Vasc Res 2004; 41:499-508
32. Grant DS, Yenisey C, Rose RW, Tootell M, Santra M, Iozzo RV: Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 2002; 21: 4765-4777
33. Ye HQ, Maeda M, Yu FS, Azar DT: Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas. Invest Ophthal-mol Vis Sci 2000; 41:2894-2899
34. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ: A model of angio-genesis in the mouse cornea. Invest Ophthal-mol Vis Sci 1996; 37:1625-1632
35. Kato T, Kure T, Chang JH, Gabison EE, Itoh T, Itohara S, Azar DT: Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett 2001; 508:187-190
36. Kojima T, Chang JH, Azar DT: Proangiogen-ic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogene-sis. Am J Pathol 20 07; 17 0 : 76 4-773
37. Beales MP, Funderburgh JL, Jester JV, Has-sell JR: Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: maintenance of the keratocyte phenotype in culture. Invest Ophthalmol Vis Sci 1999; 40: 1658-1663
38. Tam EM, Morrison CJ, Wu YI, Stack MS, Overall CM: Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloprotein-ase substrates. Proc Natl Acad Sci USA 2004; 101: 6917-6922
39. Zhou Z, Apte SS, Soininen R, Cao R, Baak-lini GY, Rauser RW, Wang J, Cao Y, Tryggva-son K: Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 2000; 97: 4052-4057
40. Jarvelainen H, Puolakkainen P, Pakkanen S, Brown EL, Hook M, Iozzo RV, Sage EH, Wight TN: A role for decorin in cutaneous wound healing and angiogenesis. Wound Repair Regen 2006; 14 : 443-452
41. Nelimarkka L, Salminen H, Kuopio T, Nik-kari S, Ekfors T, Laine J, Pelliniemi L, Jarve-lainen H: Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am J Pathol 2001; 158: 345-353